China Universal Asset Management Co., Ltd.
Position in LLY — ELI LILLY & Co
CIK 1906594
SHANGHAI, F4
Position in LLY
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$3,943,973
-$2,609,426 QoQ
Shares Held
4,288
-29.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026China Universal Asset Management Co., Ltd. holds $79,455,338 across 14 Drug Manufacturers - General names. LLY ranks #7 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
62,410 | $21,958,958 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
157,523 | $21,953,980 | |
| 3 | NVS |
Novartis AG
|
53,135 | $8,116,371 | |
| 4 | JNJ |
Johnson & Johnson
|
28,460 | $6,956,762 | |
| 5 | AZN |
Astrazeneca PLC
|
25,600 | $5,048,832 | |
| 6 | BIIB |
Biogen Inc.
|
26,044 | $4,774,646 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
4,288 | $3,943,973 | |
| 8 | SNY |
Sanofi
|
43,433 | $2,092,601 |
All Filings in LLY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,943,973 | 4,288 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $6,553,399 | 6,098 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,314,765 | 5,655 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,041,357 | 7,750 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $5,840,835 | 7,072 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $6,033,180 | 7,815 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $7,002,469 | 7,904 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $5,660,435 | 6,252 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $7,699,470 | 9,897 | Shares | Sole | 2024-05-21 | |
| 2023-12-31 | $4,824,828 | 8,277 | Shares | Sole | 2024-05-22 | |
| 2023-09-30 | $4,445,825 | 8,277 | Shares | Sole | 2024-05-22 | |
| 2023-06-30 | $5,348,247 | 11,404 | Shares | Sole | 2024-05-22 | |
| 2023-03-31 | $4,970,317 | 14,473 | Shares | Sole | 2024-05-22 | |
| 2022-12-31 | $5,328,459 | 14,565 | Shares | Sole | 2024-05-22 | |
| 2022-09-30 | $4,166,041 | 12,884 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $1,732,685 | 5,344 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $381,158 | 1,331 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $3,997,455 | 14,472 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||